Baxter International Inc.
NYSE:BAXMedical - Instruments & Supplies
-$1.07 today
- Market cap
- $13.53B
- Beta
- 0.64
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$2.13
- Dividend yield
- 1.03%
Volume 4.01M
Average 7.62M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Baxter International Inc.
NYSE:BAX
Intrinsic Alpha fair value
Locked
Current Price
$26.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A5 analysts |
| Revenue | N/A | N/A | +3.8% | +2.9% (3yr)10 analysts |
| Net Income | N/A | N/A | N/A | N/A10 analysts |
| EBIT | N/A | N/A | N/A | N/A10 analysts |
Analysis
Recent growth has been strongest in Revenue at +3.8% over three years. Forward estimates point to Revenue at +2.9% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Fresenius Medical Care AG & Co. KGaA NYSE:FMS | $12.26B | $22.03 | Not rated | 11.9 | -4.38% |
DaVita Inc. NYSE:DVA | $10.98B | $174.56 | Undervalued | 18.2 | +40.44% |
ICU Medical, Inc. NASDAQ:ICUI | $4.48B | $179.27 | Undervalued | 74.2 | +34.63% |
InfuSystem Holdings, Inc. AMEX:INFU | $294.89M | $14.72 | Undervalued | 23.2 | +58.08% |
Continue the stock analysis
Jump to another research area for this company.